HYPERKALEMIA RISK COMPARISON IN PATIENTS ON VALSARTAN SACUBITRIL: NORMAL RENAL PROFILE VERSUS ADVANCED CHRONIC KIDNEY DISEASE. RMSR 2025, 3 (5), 1163-1167.